Cargando…
Impact of thyroid disease in patients with atrial fibrillation: Analysis from the JoFib registry
BACKGROUND: Thyroid disease is a well-established risk factor for atrial fibrillation (AF). However, only a handful of studies examined its impact on treatment. This study aims to report the prevalence rate of thyroid disease in patients with AF and to demonstrate the effect of thyroid disease on AF...
Autores principales: | Al-Makhamreh, Hanna, Al-Ani, Abdallah, Alkhulaifat, Dana, Shaban, Liza, Salah, Neveen, Almarayaty, Rusul, Al-Huneidy, Yazan, Hammoudeh, Ayman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818533/ https://www.ncbi.nlm.nih.gov/pubmed/35145683 http://dx.doi.org/10.1016/j.amsu.2022.103325 |
Ejemplares similares
-
Paroxysmal and Non-Paroxysmal Atrial Fibrillation in Middle Eastern Patients: Clinical Features and the Use of Medications. Analysis of the Jordan Atrial Fibrillation (JoFib) Study
por: Al-Makhamreh, Hanna, et al.
Publicado: (2022) -
One-Year Clinical Outcome in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study
por: Hammoudeh, Ayman, et al.
Publicado: (2022) -
Demographics and Risk Profile of Elderly Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study
por: Alhaddad, Zayd, et al.
Publicado: (2022) -
Prevalence, Epidemiological Characteristics, and Pharmacotherapy of Coronary Artery Disease among Patients with Atrial Fibrillation: Data from Jo-Fib Study
por: Al-Makhamreh, Hanna K., et al.
Publicado: (2021) -
Thromboembolism and Major Bleeding in Patients with Atrial Fibrillation and EHRA Type 2 Valvular Heart Disease: The Jordan Atrial Fibrillation (JoFib) Study
por: Al-Najar, Mahasen, et al.
Publicado: (2023)